<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.australianhealthcareherald.com/article/913850666-zanda-named-best-healthcare-technology-solution-of-the-year</loc>
      <news:news>
        <news:publication>
          <news:name>Australian Healthcare Herald</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-20T15:34:06+00:00</news:publication_date>
        <news:title>Zanda Named Best Healthcare Technology Solution of the Year</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24415765-zanda-logo-3301x1276.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.australianhealthcareherald.com/article/913551899-protocol-validity-protection-added-in-penta-security-s-cloudbric-managed-rules</loc>
      <news:news>
        <news:publication>
          <news:name>Australian Healthcare Herald</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-20T06:30:00+00:00</news:publication_date>
        <news:title>Protocol Validity Protection Added in Penta Security’s Cloudbric Managed Rules</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24860244-cmr-protocol-validity-2156x993.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.australianhealthcareherald.com/article/913834519-propanc-biopharma-s-ceo-forecasts-new-medical-breakthroughs-in-the-fight-against-pancreatic-cancer-over-the-next-decade</loc>
      <news:news>
        <news:publication>
          <news:name>Australian Healthcare Herald</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-20T12:45:00+00:00</news:publication_date>
        <news:title>Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0de2a486-4708-45bf-a406-f462ad395dec/small/propanc-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.australianhealthcareherald.com/article/913836085-gelteq-commences-veterinary-medicine-clinical-trial-to-support-an-fda-regulatory-pathway</loc>
      <news:news>
        <news:publication>
          <news:name>Australian Healthcare Herald</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-20T12:00:00+00:00</news:publication_date>
        <news:title>Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/178e1a9c-f21e-4691-add7-b1398d96f7a6/small/gelteq-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.australianhealthcareherald.com/article/913637593-unchainedtv-wins-19-telly-awards-in-a-victory-for-vegan-tv-programming</loc>
      <news:news>
        <news:publication>
          <news:name>Australian Healthcare Herald</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-19T19:50:52+00:00</news:publication_date>
        <news:title>UnchainedTV Wins 19 Telly Awards in a Victory for Vegan TV Programming</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861265-new-day-new-chef-lite-telly-a-1920x1080.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.australianhealthcareherald.com/article/913649221-studyfetch-launches-honen-for-enterprise-an-agentic-learning-platform-that-builds-training-in-minutes</loc>
      <news:news>
        <news:publication>
          <news:name>Australian Healthcare Herald</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-19T17:12:47+00:00</news:publication_date>
        <news:title>StudyFetch Launches Honen for Enterprise: An Agentic Learning Platform That Builds Training in Minutes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861181-honen-logo-1600x836.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.australianhealthcareherald.com/article/913627177-propanc-biopharma-engages-european-cdmo-for-gmp-production-of-prp-for-phase-1b-fih-study-in-30-40-advanced-cancer-patients</loc>
      <news:news>
        <news:publication>
          <news:name>Australian Healthcare Herald</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-19T12:45:00+00:00</news:publication_date>
        <news:title>Propanc Biopharma Engages European CDMO for GMP Production of PRP for Phase 1b, FIH Study in 30 – 40 Advanced Cancer Patients</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0de2a486-4708-45bf-a406-f462ad395dec/small/propanc-logo-png.png</image:loc>
        </image:image>
    </url>
</urlset>
